Relation between Adiponectin and Metabolic Risk Factors

혈중 아디포카인 농도와 대사지표와의 상관관계

Park, Kyong-Soo
박경수

  • Published : 20051000

Abstract

Keywords

References

  1. Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327-332, 2000 https://doi.org/10.1016/S1043-2760(00)00301-5
  2. Fasshauer M, Paschke R: Regulation of adipocytoki-nes and insulin resistance. Diabetologia 46:1594-1603, 2003 https://doi.org/10.1007/s00125-003-1228-z
  3. 유성태, 박석오, 김세화: 혈중 아디포넥틴 및 레지스틴 농도와 대사성 위험인자의 상관관계. 대한내분비학회지 20:444-451, 2005
  4. Youn BS, Yu KY, Park HJ, Lee NS, Min SS, Youn MY, Cho YM, Park YJ, Kim SY, Lee HK, Park KS: Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150-156, 2004 https://doi.org/10.1210/jc.2003-031121
  5. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsu-noda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adi-ponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003 https://doi.org/10.1038/nature01705
  6. Kadowaki T, Yamauchi T: Adiponectin and adipone-ctin receptors. Endocr Rev 26:439-51, 2005 https://doi.org/10.1210/er.2005-0005
  7. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001 https://doi.org/10.1038/35053000
  8. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA: Regulation of fasted blood glucose by resistin. Science 303:1195-1198, 2004 https://doi.org/10.1126/science.1092341
  9. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA: Activation of SOCS-3 by resistin. Mol Cell Biol 25:1569-1575, 2005 https://doi.org/10.1128/MCB.25.4.1569-1575.2005
  10. Kusminski CM, McTernan PG, Kumar S: Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond) 109:243-256, 2005 https://doi.org/10.1042/CS20050078
  11. Chung SS, Choi HH, Kim KW, Cho YM, Lee HK, Park KS: Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site. Diabetologia 48:1150-1158, 2005 https://doi.org/10.1007/s00125-005-1762-y
  12. Jung HS, Youn BS, Cho YM, Yu KY, Park HJ, Shin CS, Kim SY, Lee HK, Park KS: The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mel-litus. Metabolism 54:314-320, 2005 https://doi.org/10.1016/j.metabol.2004.05.019
  13. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Th-romb Vasc Biol 24:29-33, 2004 https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  14. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK, Park KS: Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovascular Research 2005 (in press)